Oral beta-blockers for mild to moderate hypertension during pregnancy - Wikidata - awgldk - TriplyDB

Oral beta-blockers for mild to moderate hypertension during pregnancy

Oral beta-blockers for mild to moderate hypertension during pregnancy

http://www.wikidata.org/entity/Q24248046

about

sameAs

Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension Blood pressure lowering efficacy of partial agonist beta blocker monotherapy for primary hypertension Blood pressure lowering efficacy of nonselective beta-blockers for primary hypertension Antihypertensive drug therapy for mild to moderate hypertension during pregnancy Blood pressure lowering efficacy of partial agonist beta blockers for primary hypertension Blood pressure lowering efficacy of non-selective beta blockers for primary hypertension Blood pressure lowering efficacy of dual alpha and beta blockers for primary hypertension Blood pressure lowering efficacy of beta-1 selective beta blockers for primary hypertension Antihypertensive drug therapy for mild to moderate hypertension during pregnancy Use of antihypertensive medications in pregnancy and the risk of adverse perinatal outcomes: McMaster Outcome Study of Hypertension In Pregnancy 2 (MOS HIP 2)Essential pre-pregnancy and pregnancy interventions for improved maternal, newborn and child health.Antenatal interventions to reduce preterm birth: an overview of Cochrane Systematic Reviews.The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient care A review of the methodological features of systematic reviews in maternal medicine.Reducing stillbirths: prevention and management of medical disorders and infections during pregnancy.Acute coronary syndrome in pregnancy.Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy.Essential interventions: implementation strategies and proposed packages of care Pregnancy outcomes of anti-hypertensives for women with chronic hypertension: a population-based study.Hypoglycemia, polycythemia and hyponatremia in a newborn exposed to nebivolol during pregnancy.How to manage hypertension in pregnancy effectively.Risks of congenital malformations and perinatal events among infants exposed to calcium channel and beta-blockers during pregnancy Accuracy of ICD-9-CM coding to identify small for gestational age newborns Better than nothing? maternal, newborn, and child health services and perinatal mortality, Lubumbashi, democratic republic of the Congo: a cohort study β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study.Comparative effect sizes in randomised trials from less developed and more developed countries: meta-epidemiological assessment Hypertension in pregnancy: a review of therapeutic options.Treating Hypertension in Pregnancy.Antenatal and intrapartum interventions for preventing cerebral palsy: an overview of Cochrane systematic reviews.Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta-Analysis.Late Pregnancy β Blocker Exposure and Risks of Neonatal Hypoglycemia and Bradycardia.Intrauterine Growth Restriction. Guideline of the German Society of Gynecology and Obstetrics (S2k-Level, AWMF Registry No. 015/080, October 2016).Treatment with oral beta-blockers during pregnancy complicated by maternal heart disease increases the risk of fetal growth restriction.Rheumatic heart disease in pregnancy: a report of 2 cases.Pregnancy in Women with Cardiovascular Diseases.

P2860

Q24186037-7F119763-0B2C-4BCF-BCCB-0856ED17E82D Q24187752-8D62F728-AE08-4B73-8E6C-DDF1C7A63641 Q24187802-E95E2C20-A7E2-456D-979A-4010B0A12874 Q24200205-D84E7B34-7871-419F-A7A6-31AE226102B2 Q24200520-AFCEA5D1-D2CB-4872-90AF-1B9BA246555A Q24241856-0942C4E0-16BA-4C6B-A8D2-C1777B763EED Q24242337-AF4D2E69-4281-46BD-87A5-12DB6BAD01BA Q24242590-A4A281DE-B567-41D0-A283-770293F1E032 Q24242608-8FB1B70C-AFDF-451B-BC9A-C8AAA0A7E02B Q24246376-4A75D0EA-6414-4174-861A-05D22B2A14DD Q24796129-7B1C1E3D-910B-48EA-8CF0-D8799740BB9E Q30431637-207EDC36-0926-4149-819B-2F8180017F5F Q30578125-9B25969A-1656-48C5-A44B-51800081DCE5 Q30973898-94DE2BF1-14BD-41F6-BCD7-F80F8EB12343 Q33285704-C72E9C42-AE6C-412F-9259-F35A2E7259A1 Q33441799-AC0C1592-F46A-4B76-9A9A-A40109EBDB5C Q33860225-26BDCE3A-0C63-407D-9A4F-A10D5364861F Q33875780-DF214C4B-00F9-499F-A963-7EBB475941D5 Q34094325-0DBACC91-24A0-4B0A-BA5D-3D2981F870B4 Q34583864-E5CBAFCD-C58B-4E69-830A-A576E49CBDBA Q35056331-F74D7AA3-2FF2-4EF7-84D4-60CBF1B9519A Q35219641-1676F111-77AD-4D95-9D50-689312B87A08 Q35596724-C17EA403-A081-475A-A64E-3E90DC428343 Q35945479-12CFC625-3F72-4719-B833-F6D386ED4D4B Q36000340-38074A0F-8CA1-4DA2-A776-8DDA7CE9792E Q36107986-951009E4-12C6-4B0A-8CF5-1CB4FCC0AFC7 Q36603392-1F1F6ECD-671F-4DDC-9D5C-4B878621A521 Q37185927-42B8C99B-D5AF-466E-AE9E-ACE1BF4C276F Q38540888-4E869104-B6F1-40A6-8BA4-E956D277BC16 Q38635440-702B6672-816F-4755-AD5F-632D1FD60B5F Q38780214-B3E4F575-984B-4C63-B64A-4858AE0EF200 Q40601235-E8BEA051-834D-417D-AA88-7094D7485E9E Q49165436-0DF901EE-5A93-46B0-BBD0-519C4511C0FC Q50735977-4B198041-EA11-40A4-B5DD-9EA40E01EA03 Q55121637-A9985E4E-BCEF-4728-84FF-FEF0AF1CCAB7 Q55438509-E9621DD4-08CB-4F10-98B9-741C6013A94C

P2860

Oral beta-blockers for mild to moderate hypertension during pregnancy

http://www.wikidata.org/entity/Q24248046

description

2000 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Oral beta-blockers for mild to moderate hypertension during pregnancy

@ast

Oral beta-blockers for mild to moderate hypertension during pregnancy

@en

Oral beta-blockers for mild to moderate hypertension during pregnancy

@en-gb

Oral beta-blockers for mild to moderate hypertension during pregnancy

@nl

type

label

Oral beta-blockers for mild to moderate hypertension during pregnancy

@ast

Oral beta-blockers for mild to moderate hypertension during pregnancy

@en

Oral beta-blockers for mild to moderate hypertension during pregnancy

@en-gb

Oral beta-blockers for mild to moderate hypertension during pregnancy

@nl

altLabel

Oral beta-blockers for mild to moderate hypertension during pregnancy.

@en

prefLabel

Oral beta-blockers for mild to moderate hypertension during pregnancy

@ast

Oral beta-blockers for mild to moderate hypertension during pregnancy

@en

Oral beta-blockers for mild to moderate hypertension during pregnancy

@en-gb

Oral beta-blockers for mild to moderate hypertension during pregnancy

@nl

P1433

Q24248046-1B96E00C-F592-4AFC-B038-17CEF1166BB2

P1476

Q24248046-3B07D3B9-B8FD-40A5-B0B1-BCD211AE9CE8

Q24248046-92ECA59C-C313-40CA-AFE7-C003C33C8DAC

P2093

Q24248046-AA222B35-580B-4172-8BA1-58C2D1D2BC7B

Q24248046-E2941404-5A7D-4DB9-9447-51611071370D

P2860

Q24248046-0F8CFD78-1FDD-4913-9BAA-2E8ADF07A0D1

Q24248046-1C0144AB-9317-4038-94EA-C1708E3BFF59

Q24248046-2C3D7CFB-E96C-4DB8-9E75-FB04AE89E2A8

Q24248046-2EEBF6CF-9E1B-49CA-823A-0C9DE053FD9D

Q24248046-32E2AD7F-D30C-46B6-B5AF-7D14DAB99568

Q24248046-4004EE95-5B2F-4021-A0EA-6441A381D156

Q24248046-42CF9352-91CB-48C7-8631-75EF4FEF69B6

Q24248046-44D25580-3180-4E92-A6B8-CB0B75015212

Q24248046-492DDD0A-44C7-46BC-9E71-7FC25679CB1A

Q24248046-4DBF9B75-EC5B-479E-959B-5FF173C5932A

P304

Q24248046-2068D408-7B25-4A37-A377-76E662BB36AB

P31

Q24248046-7F9661CF-8C9A-4254-9B6E-669DC6C4600E

P3181

Q24248046-E1FB1F20-3161-4649-9F02-E988A42A3BEF

P356

Q24248046-694CF7C2-9D5F-44AE-9D77-ECC8F272A3B3

P433

Q24248046-8F0D90B9-D24C-4462-B60E-114C984495F7

P50

Q24248046-D3799006-6754-43D3-B139-5CB6256DA231

P577

Q24248046-AA408D4D-1C9F-4E88-A14F-21DCBB43BB32

Q24248046-BCE4ECF7-73FA-4C47-B2FF-D779C97FE15A

P698

Q24248046-4B049204-7BB7-4541-9F1D-68A46C4E218C

Q24248046-C459B9AB-D4B1-48F9-AD7B-37ACA27D9C21

P921

Q24248046-D3809D3E-B252-4D9D-8E92-8B7168F31961

Q24248046-DE30EBDD-D152-4374-ADC2-A41492CD04DE

P3181

P356

14651858.CD002863

P1433

Cochrane Database of Systematic Reviews

P1476

Oral beta-blockers for mild to moderate hypertension during pregnancy

@en

Oral beta-blockers for mild to moderate hypertension during pregnancy.

@en

P2093

L A Magee

http://www.w3.org/2001/XMLSchema#string

Laura Magee

http://www.w3.org/2001/XMLSchema#string

P2860

An assessment of clinically useful measures of the consequences of treatment

The detection, investigation and management of hypertension in pregnancy: executive summary.

First year of life after the use of atenolol in pregnancy associated hypertension

Atenolol in essential hypertension during pregnancy

Randomised controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics.

Glycemia in newborns of hypertensive mothers according to maternal treatment.

Management of severe, early pre-eclampsia: is conservative management justified?

Does labetalol influence the development of proteinuria in pregnancy hypertension? A randomised controlled study.

A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy.

Comparison of outcome of labetalol or hydralazine therapy during hypertension in pregnancy in very low birth weight infants.

P304

CD002863

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2082701

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/14651858.CD002863

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P50

P577

2000-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2003-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11034777

http://www.w3.org/2001/XMLSchema#string

12917933

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension

maternal health